Abcellera Biologics is trading 4.27% up at $12.32, a move consistent with broader-market gains; no company-specific catalyst was identified for October 26.
- The S&P 500 was up 0.93% and Nasdaq Composite up 1.28%, pointing to broad market sentiment rather than a clearly identified company event.
- The latest listed company news release is dated October 8; market coverage also reported no new catalyst today.